Whitehawk Therapeutics, Inc. — Director's Dealing 2021

Nov 29, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aadi Bioscience, Inc. (AADI)
CIK: 0001422142
Period of Report: 2021-11-28

Reporting Person: Giacobello Scott M. (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option (right to buy)	$27.40	2031-11-01	Common Stock (200000)		Direct

Footnotes

F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean November 1, 2021.